AGM
IMVT icon

Alpine Global Management’s Immunovant IMVT Stock Holding History

Alpine Global Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$65.5M Buy
2,636,925
+10,233
+0.4% +$265K 9.81% 1
2025
Q4 		$66.8M Sell
2,626,692
-128,039
-5% -$2.86M 14.39% 1
2025
Q3 		$44.4M Buy
2,754,731
+128,039
+5% +$2.07M 9% 2
2025
Q2 		$42M Hold
2,626,692
– – 9.47% 3
2025
Q1 		$44.9M Sell
2,626,692
-1,691,116
-39% -$35.4M 11.88% 2
2024
Q4 		$107M Buy
4,317,808
+2,435,104
+129% +$69.1M 13.99% 2
2024
Q3 		$53.7M Sell
1,882,704
-25,000
-1% -$737K 12.99% 1
2024
Q2 		$50.4M Buy
1,907,704
+25,000
+1% +$711K 8.76% 1
2024
Q1 		$60.8M Buy
1,882,704
+484,332
+35% +$17.7M 11.78% 1
2023
Q4 		$58.9M Buy
1,398,372
+145,898
+12% +$5.37M 16.09% 1
2023
Q3 		$48.1M Sell
1,252,474
-187,070
-13% -$4.23M 11.09% 3
2023
Q2 		$27.3M Hold
1,439,544
– – 7.52% 2
2023
Q1 		$22.3M Sell
1,439,544
-60,456
-4% -$1.05M 8.67% 3
2022
Q4 		$26.6M Sell
1,500,000
-2,848,017
-66% -$35.9M 8.85% 2
2022
Q3 		$24.3M Sell
4,348,017
-100,000
-2% -$489K 5.68% 4
2022
Q2 		$17.3M Buy
4,448,017
+586,228
+15% +$2.53M 4.39% 4
2022
Q1 		$21.3K Buy
3,861,789
+854,789
+28% +$5.32M 4.82% 3
2021
Q4 		$25.6M Buy
3,007,000
+6,800
+0.2% +$56.1K 3.77% 1
2021
Q3 		$26.1M Buy
3,000,200
+1,000,200
+50% +$9.02M 5.92% 2
2021
Q2 		$21.1M Buy
2,000,000
+903,022
+82% +$12.6M 2.88% 9
2021
Q1 		$17.6M Buy
+1,096,978
New +$28.9M 1.69% 18

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Alpine Global Management's IMVT Position: Q1 2026 in Review

Alpine Global Management increased its Immunovant (IMVT) stake by 0.39% in Q1 2026, buying an estimated $265K and bringing the position to 2,636,925 shares worth $65.5M. The position accounts for 9.81% of the portfolio, ranked #1.

Alpine Global Management first reported a position in IMVT in Q1 2021 and has held it in 21 quarters since. The position peaked at $107M in Q4 2024. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Alpine Global Management held 2,636,925 shares of Immunovant worth $65.5M as of Q1 2026.
  • Alpine Global Management bought 10,233 Immunovant shares in Q1 2026, an estimated $265K.
  • Immunovant made up 9.81% of Alpine Global Management's portfolio in Q1 2026, its #1 holding.
  • Alpine Global Management first reported a position in Immunovant in Q1 2021 and has held it in 21 quarters since.
  • Alpine Global Management's Immunovant position peaked at $107M in Q4 2024.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Alpine Global Management's 13F filing for Q1 2026, filed 15 May 2026.